The role of hypoxia-inducible factor-2 in digestive system cancers
Open accessAbstract
Hypoxia is an all but ubiquitous phenomenon in cancers. Two known hypoxia-inducible factors (HIFs), HIF-1 α and HIF-2 α , primarily mediate the transcriptional response to hypoxia. Despite the high homology between HIF-1 α and HIF-2 α , emerging evidence suggests differences between both molecules in terms of transcriptional targets as well as impact on multiple physiological pathways and tumorigenesis. To date, much progress has been made toward understanding the roles of HIF-2 α in digestive system cancers. Indeed, HIF-2 α has been shown to regulate multiple aspects of digestive system cancers, including cell proliferation, angiogenesis and apoptosis, metabolism, metastasis and resistance to chemotherapy. These findings make HIF-2 α a critical regulator of this malignant phenotype. Here we summarize the function of HIF-2 during cancer development as well as its contribution to tumorigenesis in digestive system malignancies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
EPO is often considered a prototypical HIF-2 target, although regulation by all three HIF isoforms has also been reported.
“Erythropoietin (EPO) is often considered a prototypical HIF-2 target [65,100], although regulation by all three HIF isoforms has also been reported [101]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [65]
HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis.
“Given that HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis69,70”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · see citing works
RetractedLysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309 · see citing works
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · see citing works
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172 · see citing works
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600 · see citing works
(1999) · PubMed · Cited by 2,204 · see citing works
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712 · see citing works
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · see citing works
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577 · see citing works
Bax directly induces release of cytochrome c from isolated mitochondria
Jürgensmeier, J. M., Xie, Z., Deveraux, Q. L., Ellerby, L., Bredesen, D. E., & Reed, J. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4997 · Cited by 1,523 · see citing works
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385 · see citing works
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · see citing works
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354 · see citing works
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351 · see citing works
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312 · see citing works
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179 · see citing works
Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., & Fujii-Kuriyama, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4273 · Cited by 1,016 · see citing works
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941 · see citing works
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940 · see citing works
Mignotte, B., & Vayssière, J. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520001.x · Cited by 882 · see citing works
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870 · see citing works
The role of hypoxia-inducible factors in tumorigenesis
Rankin, E. B., & Giaccia, A. J. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.21 · Cited by 806 · see citing works
HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation
Gordan, J. D., Thompson, C. B., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.006 · Cited by 806 · see citing works
HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity
Gordan, J. D., Bertout, J. A., Hu, C.-J., Diehl, J. A., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.006 · Cited by 781 · see citing works
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761 · see citing works
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs
Wiesener, M. S., Jürgensen, J. S., Rosenberger, C., Scholze, C. K., Hörstrup, J. H., Warnecke, C., Mandriota, S. J., Bechmann, I., Frei, U. A., Pugh, C. W., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0445fje · Cited by 741 · see citing works
Holmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, Å., Gradin, K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.026 · Cited by 735 · see citing works
DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W. (2008) · Genes & Development · doi:10.1101/gad.1617608 · Cited by 710 · see citing works
HIF-1α induces cell cycle arrest by functionally counteracting Myc
Koshiji, M., Kageyama, Y., Pete, E. A., Horikawa, I., Barrett, J. C., & Huang, L. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600196 · Cited by 652 · see citing works
Beyond tumorigenesis: cancer stem cells in metastasis
Li, F., Tiede, B., Massagué, J., & Kang, Y.-B. (2007) · Cell Research · doi:10.1038/sj.cr.7310118 · Cited by 651 · see citing works
Tian, H., Hammer, R. E., Matsumoto, A. M., Russell, D. W., & McKnight, S. L. (1998) · Genes & Development · doi:10.1101/gad.12.21.3320 · Cited by 647 · see citing works
Wiesener, M. S., Turley, H., Allen, W. E., Willam, C., Eckardt, K., Talks, K., Wood, S. M., Gatter, K. C., Harris, A. L., Pugh, C. W., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2260 · Cited by 629 · see citing works
Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611 · see citing works
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo
Rankin, E. B., Biju, M. P., Liu, Q., Unger, T. L., Rha, J., Johnson, R. S., Simon, M. C., Keith, B., & Haase, V. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30117 · Cited by 596 · see citing works
Passing the baton: the HIF switch
Koh, M. Y., & Powis, G. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.004 · Cited by 589 · see citing works
Gu, Y.-Z., Moran, S. M., Hogenesch, J. B., Wartman, L. D., & Bradfield, C. A. (1998) · Europe PMC (PubMed Central) · Cited by 577 · see citing works
Mole, D. R., Blancher, C., Copley, R. R., Pollard, P. J., Gleadle, J. M., Ragoussis, J., & Ratcliffe, P. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901790200 · Cited by 552 · see citing works
Shaw, R. J. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.10.005 · Cited by 543 · see citing works
Tang, N., Wang, L., Esko, J. D., Giordano, F. J., Huang, Y., Gerber, H., Ferrara, N., & Johnson, R. S. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.026 · Cited by 540 · see citing works
Hogenesch, J. B., Chan, W. K., Jackiw, V., Brown, R. C., Gu, Y.-Z., Pray-Grant, M. G., Perdew, G. H., & Bradfield, C. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8581 · Cited by 514 · see citing works
Scortegagna, M., Ding, K., Oktay, Y., Gaur, A., Thurmond, F., Yan, L.-J., Marck, B. T., Matsumoto, A. M., Shelton, J. M., Richardson, J. A., et al. (2003) · Nature Genetics · doi:10.1038/ng1266 · Cited by 496 · see citing works
HIF activation identifies early lesions in VHL kidneys
Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00071-5 · Cited by 483 · see citing works
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
Arabi, A., Wu, S., Ridderstråle, K., Bierhoff, H., Shiue, C.-N., Fátyol, K., Fahlén, S., Hydbring, P., Söderberg, O., Grummt, I., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1225 · Cited by 471 · see citing works
(2002) · PubMed · Cited by 457 · see citing works
Hypoxia inducible factors in cancer stem cells
Heddleston, J. M., Li, Z., Lathia, J. D., Bao, S., Hjelmeland, A. B., & Rich, J. N. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605551 · Cited by 453 · see citing works
Hypoxia-inducible factors: central regulators of the tumor phenotype
Gordan, J. D., & Simon, M. C. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.006 · Cited by 450 · see citing works
Maranchie, J. K., Vasselli, J. R., Riss, J., Bonifacino, J. S., Linehan, W. M., & Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00044-2 · Cited by 433 · see citing works
Lum, J. J., Bui, T., Gruber, M., Gordan, J. D., DeBerardinis, R. J., Covello, K. L., Simon, M. C., & Thompson, C. B. (2007) · Genes & Development · doi:10.1101/gad.1529107 · Cited by 429 · see citing works
Activation of the HIF pathway in cancer
Maxwell, P. H. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 426 · see citing works
Regulation of Angiogenesis by Oxygen and Metabolism
Fraisl, P., Mazzone, M., Schmidt, T., & Carmeliet, P. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.003 · Cited by 409 · see citing works
Oxygen: Modulator of metabolic zonation and disease of the liver
Jungermann, K., & Kietzmann, T. (2000) · Hepatology · doi:10.1002/hep.510310201 · Cited by 387 · see citing works
Imai, T., Horiuchi, A., Wang, C., Oka, K., Ohira, S., Nikaido, T., & Konishi, I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63501-8 · Cited by 377 · see citing works
Flamme, I., Fröhlich, T., von Reutern, M., Kappel, A., Damert, A., & Risau, W. (1997) · Mechanisms of Development · doi:10.1016/s0925-4773(97)00674-6 · Cited by 366 · see citing works
Koh, M. Y., Lemos, R., Liu, X., & Powis, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4142 · Cited by 350 · see citing works
HIF-1α Induces Genetic Instability by Transcriptionally Downregulating MutSα Expression
Koshiji, M., To, K. K.-W., Hammer, S., Kumamoto, K., Harris, A. L., Modrich, P., & Huang, L. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.015 · Cited by 346 · see citing works
Hui, E. P., Chan, A. T. �., Pezzella, F., Turley, H., To, K., Poon, T. C. W., Zee, B. C.-Y., Mo, F. K. F., Teo, P. M. L., Huang, D. P., et al. (2002) · PubMed · Cited by 304 · see citing works
Qian, D. Z., Kachhap, S. K., Collis, S. J., Verheul, H. M. W., Carducci, M. A., Atadja, P. W., & Пили, Р. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4598 · Cited by 302 · see citing works
Regulation of E-cadherin Expression by <i>VHL</i> and Hypoxia-Inducible Factor
Esteban, M. A., Tran, M. G. B., Harten, S. K., Hill, P., Castellanos, M. C., Chandra, A., Raval, R., O'Brien, T. S., & Maxwell, P. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2670 · Cited by 262 · see citing works
Kong, X., Lin, Z., Liang, D., Fath, D., Sang, N., & Caro, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2019-2028.2006 · Cited by 258 · see citing works
HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses
Bertout, J. A., Majmundar, A. J., Gordan, J. D., Lam, J. C., Ditsworth, D., Keith, B., Brown, E. J., Nathanson, K. L., & Simon, M. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907357106 · Cited by 196 · see citing works
Qu, A., Taylor, M. J., Xue, X., Matsubara, T., METZGER, D., Chambon, P., Gonzalez, F. J., & Shah, Y. M. (2011) · Hepatology · doi:10.1002/hep.24400 · Cited by 181 · see citing works
Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients
Yoshimura, H., Dhar, D. K., Kohno, H., Kubota, H., Fujii, T., Ueda, S., Kinugasa, S., Tachibana, M., & Nagasue, N. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0946-03 · Cited by 174 · see citing works
Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
Branco-Price, C., Zhang, N., Schnelle, M., Evans, C., Katschinski, D. M., Liao, D., Ellies, L., & Johnson, R. S. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.11.017 · Cited by 168 · see citing works
HIF‐1α and HIF‐2α have divergent roles in colon cancer
Imamura, T., Kikuchi, H., Herráiz, M., Park, D., Mizukami, Y., Mino-Kenudson, M. A., Lynch, M. P., Rueda, B. R., Benita, Y., Xavier, R. J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24032 · Cited by 159 · see citing works
Atypical BH3-domains of BNIP3 and BNIP3L lead to autophagy in hypoxia
Mazure, N. M., & Pouysségur, J. (2009) · Autophagy · doi:10.4161/auto.9042 · Cited by 146 · see citing works
Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice
Rankin, E. B., Rha, J., Unger, T. L., Wu, C., Shutt, H. P., Johnson, R. S., Simon, M. C., Keith, B., & Haase, V. H. (2008) · Oncogene · doi:10.1038/onc.2008.160 · Cited by 145 · see citing works
Zhao, D., Zhai, B., He, C., Tan, G., Jiang, X. L., Pan, S., Dong, X., Wei, Z., Ma, L., Qiao, H., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.026 · Cited by 142 · see citing works
Menrad, H., Werno, C., Schmid, T., Copanaki, E., Deller, T., Dehne, N., & Brüne, B. (2010) · Hepatology · doi:10.1002/hep.23597 · Cited by 132 · see citing works
HIF-2α deletion promotes Kras-driven lung tumor development
Mazumdar, J., Hickey, M. M., Pant, D. K., Durham, A. C., Sweet-Cordero, A., Vachani, A., Jacks, T., Chodosh, L. A., Kissil, J. L., Simon, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001296107 · Cited by 130 · see citing works
Human cancers converge at the HIF-2α oncogenic axis
Franovic, A., Holterman, C. E., Payette, J., & Lee, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906432106 · Cited by 128 · see citing works
Yang, H., Li, T. W. H., Peng, J. W., Tang, X., Ko, K. S., Xia, M., & Aller, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.044 · Cited by 128 · see citing works
Hypoxia‐inducible factors in stem cells and cancer
Mazumdar, J., Dondeti, V. R., & Simon, M. C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00963.x · Cited by 127 · see citing works
Salnikov, A. V., Liu, L., Platen, M., Gladkich, J., Salnikova, O. V., Ryschich, E., Mattern, J., Moldenhauer, G., Werner, J., Schemmer, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046391 · Cited by 126 · see citing works
Covello, K. L., Simon, M. C., & Keith, B. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3246 · Cited by 121 · see citing works
Chun, S. Y., Johnson, C., Washburn, J. G., Cruz-Correa, M. R., Dang, D. T., & Dang, L. H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-293 · Cited by 109 · see citing works
Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma
Bangoura, G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i23.3176 · Cited by 106 · see citing works
Rabbani, Z. N., Spasojević, I., Zhang, X., Moeller, B. J., Haberle, S., Vasquez-Vivar, J. M., Dewhirst, M. W., Vujašković, Ž., & Batinic̈‐Haberle, I. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.001 · Cited by 103 · see citing works
Winter, S. C., SHAH, K. A., Han, C., Campo, L., Turley, H., Leek, R., Corbridge, R., Cox, G. J., & Harris, A. L. (2006) · Cancer · doi:10.1002/cncr.21983 · Cited by 94 · see citing works
Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes
Eubank, T. D., Roda, J. M., Liu, H., O'Neil, T., & Marsh, C. B. (2010) · Blood · doi:10.1182/blood-2010-01-261792 · Cited by 94 · see citing works
Akeno, N., Czyzyk-Krzeska, M., Gross, T. S., & Clemens, T. L. (2001) · Endocrinology · doi:10.1210/endo.142.2.8112 · Cited by 93 · see citing works
Opposite effects of HIF-1α and HIF-2α on the regulation of IL-8 expression in endothelial cells
Florczyk, U., Czauderna, S., Stachurska, A., Tertil, M., Nowak, W. N., Kozakowska, M., Poellinger, L., Józkowicz, A., Łoboda, A., & Dulak, J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.023 · Cited by 88 · see citing works
Gan, B., Melkoumian, Z. K., Wu, X., Guan, K., & Guan, J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411106 · Cited by 86 · see citing works
Arya, M., Ahmed, H. U., Silhi, N., Williamson, M. P., & Patel, H. (2007) · Tumor Biology · doi:10.1159/000102979 · Cited by 81 · see citing works
Sun, H.-X., Xu, Y., Yang, X., Wang, W., Bai, H., Shi, R.-Y., Nayar, S. K., Devbhandari, R. P., He, Y.-Z., Zhu, Q.-F., et al. (2012) · Hepatology · doi:10.1002/hep.26188 · Cited by 79 · see citing works
HIF-2α Enhances β-Catenin/TCF-Driven Transcription by Interacting with β-Catenin
Choi, H., Chun, Y.-S., Kim, T.-Y., & Park, J.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0505 · Cited by 79 · see citing works
Liu, Y.-L., Yu, J., Song, X., Wang, X.-W., Xing, L., & Gao, B. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3162 · Cited by 78 · see citing works
Li, Q., Sun, Y., Ruan, C., Xu, X., Ge, J., He, J., Xu, Z., Wang, Q., & Gao, W. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01811.x · Cited by 73 · see citing works
Das, B., Bayat‐Mokhtari, R., Tsui, M., Lotfi, S., Tsuchida, R., Felsher, D. W., & Yeger, H. (2012) · Stem Cells · doi:10.1002/stem.1142 · Cited by 73 · see citing works
Xue, X., & Shah, Y. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs313 · Cited by 73 · see citing works
Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer
Koukourakis, M. I., Giatromanolaki, A. N., Polychronidis, A., Simopoulos, C., Gatter, K. C., Harris, A. L., & Sivridis, E. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00220.x · Cited by 70 · see citing works
Yang, S., Liu, L.-P., Jiang, J., Xiong, Z., He, Q.-J., & Wu, C. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt194 · Cited by 69 · see citing works
Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses
Yoon, H., Shin, S.-H., Shin, D. H., Chun, Y., & Park, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.001 · Cited by 65 · see citing works
Burkitt, K., Chun, S. Y., Dang, D. T., & Dang, L. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0944 · Cited by 61 · see citing works
Wang, J., Ma, Y., Jiang, H., Zhu, H., Liu, L., Sun, B., Pan, S., Krissansen, G. W., & Sun, X. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.043 · Cited by 61 · see citing works
HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer
Wang, Y., Li, Z., Zhang, H., Jin, H., Sun, L. J., Dong, H., Xu, M., Zhao, P., Zhang, B., Wang, J., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.4.12441 · Cited by 57 · see citing works
Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions
Chae, K. S., Kang, M. J., Lee, J., Ryu, B. K., Lee, M. G., Her, N.-G., Ha, T. K., Han, J., Kim, Y. K., & G, S. (2010) · Oncogene · doi:10.1038/onc.2010.498 · Cited by 54 · see citing works
PanIN-specific regulation of Wnt signaling by HIF2α during early pancreatic tumorigenesis
Criscimanna, A., Duan, L.-J., Rhodes, J., Fendrich, V., Wickline, E., Hartman, D., Monga, S., Lotze, M., Gittes, G., Fong, G., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0566 · Cited by 51 · see citing works
Wen, Y., Stevens, P. D., Gasser, M. L., Andrei, R., & Gao, T. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00695-13 · Cited by 47 · see citing works
HIF1 Contributes to Hypoxia-Induced Pancreatic Cancer Cells Invasion via Promoting QSOX1 Expression
Shi, C., Fan, Y., Liu, B., & Lou, W. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354460 · Cited by 46 · see citing works
Prestigiacomo, C. J., Balmaceda, C. M., & Dalmau, J. O. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8 · Cited by 44 · see citing works
Bhatt, R. S., Landis, D. M., Zimmer, M., Torregrossa, J., Chen, S., Sukhatme, V. P., Iliopoulos, O., Balk, S., & Bubley, G. J. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07558.x · Cited by 33 · see citing works
New Agents and New Targets for Renal Cell Carcinoma
Philips, G. K., & Atkins, M. B. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e222 · Cited by 31 · see citing works
Grkovic, T., Whitson, E. L., Rabe, D. C., Gardella, R. S., Bottaro, D. P., Linehan, W. M., McMahon, J. B., Gustafson, K. R., & McKee, T. C. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.127 · Cited by 26 · see citing works
An (2010) · International Journal of Oncology · doi:10.3892/ijo_00000817 · Cited by 24 · see citing works
Cleven, A. H. G., Wouters, B. G., Schütte, B., Spiertz, A. J., van Engeland, M., & A, A. P. D. B. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604547 · Cited by 11 · see citing works
Joseph, I., Elizabeth, J., Rao, U. K., & Ranganathan, K. (2020) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_42_19 · Cited by 9 · see citing works
Härter, M. W., Thierauch, K., Boyer, S. J., Bhargava, A., Ellinghaus, P., Beck, H., Greschat, S., Hess‐Stumpp, H., & Unterschemmann, K. (2013) · ChemMedChem · doi:10.1002/cmdc.201300357 · Cited by 6 · see citing works
HIF-2α - a mediator of stem cell altruism?
Cummins, E. P. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt143 · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 111 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021 · see citing works
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico‐Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,035 · see citing works
Courtney, K. D., Infante, J. R., Lam, E. T., Figlin, R. A., Rini, B. I., Brugarolas, J., Zojwalla, N. J., Lowe, A. M., Wang, K., Wallace, E. M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.2627 · Cited by 393 · see citing works
Choueiri, T. K., Bauer, T. M., Papadopoulos, K. P., Plimack, E. R., Merchan, J. R., McDermott, D. F., Michaelson, M. D., Appleman, L. J., Thamake, S., Perini, R. F., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01324-7 · Cited by 305 · see citing works
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018) · Angiogenesis · doi:10.1007/s10456-018-9600-2 · Cited by 288 · see citing works
Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
Joseph, J. P., Harishankar, M. K., Pillai, A. A., & Devi, A. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.03.004 · Cited by 281 · see citing works
Lissanu, Y., Sun, Y., Terranova, C. J., Khan, F., Martínez-Ledesma, E., Gay, J. P., Gao, G., Mullinax, R. A., Khor, T. O., Feng, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0019-5 · Cited by 262 · see citing works
Therapies targeting cancer stem cells: Current trends and future challenges
Dragu, D. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i9.1185 · Cited by 271 · see citing works
A small molecule HIF-1α stabilizer that accelerates diabetic wound healing
Li, G., Ko, C.-N., Li, D., Yang, C., Wang, W., Yang, G., Primo, C. D., Wong, V. K. W., Xiang, Y., Lin, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23448-7 · Cited by 263 · see citing works
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Svegliati‐Baroni, G., Pierantonelli, I., Torquato, P., Marinelli, R., Ferreri, C., Chatgilialoglu, C., Bartolini, D., & Galli, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.029 · Cited by 250 · see citing works
Tian, X.-P., Wang, C.-Y., Jin, X.-H., Li, M., Wang, F., Huang, W.-J., Yun, J., Xu, R., Cai, Q.-Q., & Xie, D. (2019) · Theranostics · doi:10.7150/thno.30958 · Cited by 246 · see citing works
Kurihara, T., Westenskow, P. D., Gantner, M. L., Usui, Y., Schultz, A. W., Bravo, S., Aguilar, E., Wittgrove, C. M., Friedlander, M. S. H., Paris, L. P., et al. (2016) · eLife · doi:10.7554/elife.14319 · Cited by 214 · see citing works
Hypoxia inducible factor as a therapeutic target for atherosclerosis
Jain, T., Nikolopoulou, E. A., Xu, Q., & Qu, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.003 · Cited by 214 · see citing works
Role of OCT4 in cancer stem-like cells and chemotherapy resistance
Mohiuddin, I. S., Wei, S., & Kang, M. H. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.03.005 · Cited by 194 · see citing works
Gao, X. Y., & Schöttker, B. (2017) · Oncotarget · doi:10.18632/oncotarget.17128 · Cited by 169 · see citing works
Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction
Fricker, M., Goggins, B. J., Mateer, S. W., Jones, B., Kim, R., Gellatly, S. L., Jarnicki, A., Powell, N., Oliver, B. G. G., Radford‐Smith, G. L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.94040 · Cited by 169 · see citing works
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00408-7 · Cited by 143 · see citing works
Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
Dianat-Moghadam, H., Heidarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., & Nouri, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.043 · Cited by 140 · see citing works
Zhang, Q., Lou, Y., Zhang, J., Fu, Q., Wei, T., Sun, X., Chen, Q., Yang, J., Bai, X., & Liang, T. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0689-5 · Cited by 127 · see citing works
Yadav, A. K., & Desai, N. S. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09887-2 · Cited by 126 · see citing works
Dong, X., Liu, T., Zhi, X., Zou, J., Zhong, J., Li, T., Mo, X.-L., Zhou, W., Guo, W., Liu, X., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2725 · Cited by 95 · see citing works
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead
Aslan, M., Shahbazi, R., Ulubayram, K., & Özpolat, B. (2018) · Anticancer Research · doi:10.21873/anticanres.13026 · Cited by 88 · see citing works
Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression
Tirosh, O. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2548154 · Cited by 77 · see citing works
Yang, J., Zhang, X., Zhang, Y., Zhu, D., Zhang, L., Li, Y., Zhu, Y., Li, D., & Zhou, J. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0298-y · Cited by 76 · see citing works
The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors
Zhao, J., Du, F., Luo, Y., Shen, G., Zheng, F., & Xu, B. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.004 · Cited by 59 · see citing works
Self-citationZhou, R., Zhou, X., Yin, Z., Guo, J., Hu, T., Jiang, S., Liu, L., Dong, X., Zhang, S., & Wu, G. (2015) · Oncotarget · doi:10.18632/oncotarget.6338 · Cited by 56 · see citing works
Yuan, S., Xiang, Y., Wang, G., Zhou, M., Meng, G., Liu, Q., Hu, Z., Li, C., Xie, W., Wu, N., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12437 · Cited by 56 · see citing works
Anticancer Activity of Garcinia morella on T-Cell Murine Lymphoma Via Apoptotic Induction
Choudhury, B., Kandimalla, R., Bharali, R., Monisha, J., Kunnumakkara, A. B., Kalita, K., & Kotoky, J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00003 · Cited by 55 · see citing works
Moszyńska, A., Jaśkiewicz, M., Serocki, M., Cabaj, A., Crossman, D. K., Bartoszewska, S., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · The FASEB Journal · doi:10.1096/fj.202101987r · Cited by 53 · see citing works
Xia, J., Liu, G.-H., Chen, Z.-Y., Mao, C., Zhou, D.-C., Wu, H.-Y., Park, K., Zhao, H., Kim, S., Cai, D., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.02.007 · Cited by 48 · see citing works
Kumar, S., Verma, P. K., Shukla, A., Singh, R. K., Patel, A. K., Yadav, L., Kumar, S., Kumar, N., Kaushalendra, K., & Acharya, A. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115849 · Cited by 47 · see citing works
USP5 promotes breast cancer cell proliferation and metastasis by stabilizing HIF2α
Huang, W., Liu, X., Zhang, Y., Deng, M., Li, G., Chen, G., Li, Y., Jin, L., Liu, T., Wang, Y., et al. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30686 · Cited by 46 · see citing works
Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)
Ban, H. S., Uto, Y., Won, M., & Nakamura, H. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1146252 · Cited by 44 · see citing works
Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan
Ren, X., Diao, X., Zhuang, J., & Wu, D. (2022) · Molecular Pharmacology · doi:10.1124/molpharm.122.000525 · Cited by 43 · see citing works
Zakharia, Y., Bhattacharya, A., & Rustum, Y. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24297 · Cited by 43 · see citing works
Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy
Su, J., Zhao, Q., Zheng, Z., Wang, H., Bian, C., Meng, L., Xin, Y., & Jiang, X. M. (2022) · Antioxidants · doi:10.3390/antiox11050921 · Cited by 42 · see citing works
Chen, C., Yang, Q., Wang, D., Luo, F., Liu, X., Xue, J., Yang, P., Xu, H., Lü, J., Zhang, A., et al. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.12.016 · Cited by 41 · see citing works
High Altitude and Cancer Mortality
Thiersch, M., & Swenson, E. R. (2018) · High Altitude Medicine & Biology · doi:10.1089/ham.2017.0061 · Cited by 40 · see citing works
Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016–2020)
Ban, H. S., Uto, Y., & Nakamura, H. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1874345 · Cited by 40 · see citing works
Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing
Depping, R., JELKMANN, W. E. B., & Kosyna, F. K. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1276-0 · Cited by 39 · see citing works
Oh, E., Kim, C. W., Kim, S., Lee, J., Hong, S., & Park, H. J. (2016) · Scientific Reports · doi:10.1038/srep27382 · Cited by 39 · see citing works
The regulatory mechanisms of oncomiRs in cancer
Otmani, K., Rouas, R., Berehab, M., & Lewalle, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116165 · Cited by 40 · see citing works
Jin, Y., Che, X., Qu, X., Li, X., Lü, W., Wu, J., Wang, Y., Hou, K., Li, C., Zhang, X., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01612 · Cited by 37 · see citing works
Kast, B., Schori, C., & Grimm, C. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.12.008 · Cited by 34 · see citing works
PACAP and VIP regulate hypoxia-inducible factors in neuroblastoma cells exposed to hypoxia
Maugeri, G., D’Amico, A. G., Rasà, D. M., Saccone, S., Federico, C., Cavallaro, S., & D’Agata, V. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.04.009 · Cited by 34 · see citing works
Li, W., He, X., Xue, R., Zhang, Y., Zhang, X., Lu, J., Zhang, Z., & Li, X. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.06.013 · Cited by 32 · see citing works
HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases
Li, R., He, L., Zhang, Q. H., Liu, J., Lü, F., Duan, H., Fan, L., Peng, W., Huang, Y., & Wu, C. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s274980 · Cited by 32 · see citing works
Hypoxia-inducible factor-2α is crucial for proper brain development
Kleszka, K., Leu, T., Quinting, T., Jastrow, H., Pechlivanis, S., Fandrey, J., & Schreiber, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75838-4 · Cited by 31 · see citing works
Dietary luteolin protects against renal anemia in mice
Li, S., Jiang, H., Han, B., Kong, T., Lv, Y., Yang, Q., Wu, P., Lv, Z., & Zhang, Z. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103740 · Cited by 29 · see citing works
Maji, P., Shah, E. J., & Paul, S. (2016) · Information Sciences · doi:10.1016/j.ins.2016.06.034 · Cited by 28 · see citing works
Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
Lian, M., Mortoglou, M., & Onganer, P. U. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45120611 · Cited by 27 · see citing works
Regulation of the HIF switch in human endothelial and cancer cells
Slawski, J., Jaśkiewicz, M., Barton, A., Kozioł, S., Collawn, J. F., & Bartoszewski, R. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151386 · Cited by 26 · see citing works
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma
Nguyen, C. B., Oh, E., Bahar, P., Vaishampayan, U. N., Else, T., & Alva, A. S. (2024) · Cancers · doi:10.3390/cancers16030601 · Cited by 25 · see citing works
Hypoxia inhibits TNF-α-induced TSLP expression in keratinocytes
Tashiro, N., Segawa, R., Tobita, R., Asakawa, S., Mizuno, N., Hiratsuka, M., & Hirasawa, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224705 · Cited by 26 · see citing works
Iorio, J., Lastraioli, E., Tofani, L., Petroni, G., Antonuzzo, L., Messerini, L., Perrone, G., Caputo, D. D., Francesconi, M. A., Amato, M., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.01.001 · Cited by 24 · see citing works
Xu, W., Luo, F., Sun, B., Ye, H., Li, J., Shi, L., Liu, Y., Lü, X., Wang, B., Wang, Q., et al. (2015) · Toxicology Research · doi:10.1039/c5tx00225g · Cited by 24 · see citing works
Reduced cancer mortality at high altitude: The role of glucose, lipids, iron and physical activity
Thiersch, M., Swenson, E. R., Haider, T., & Gassmann, M. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.048 · Cited by 23 · see citing works
Klomp, J. A., Hyun, J., Klomp, J. E., Pajcini, K. V., Rehman, J., & Malik, A. B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011822 · Cited by 20 · see citing works
Zhao, F., Liu, A., Gong, X., Chen, H., Wei, J., Chen, B., Chen, S., Yang, R., Fan, Y., & Mao, R. (2021) · Tumori Journal · doi:10.1177/03008916211026019 · Cited by 21 · see citing works
Updated perspective of EPAS1 and the role in pulmonary hypertension
Wang, N., Hua, J., Fu, Y., An, J., Chen, X., Wang, C., Zheng, Y., Wang, F., Ji, Y., & Li, Q. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1125723 · Cited by 20 · see citing works
Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein
Hu, J., LIU, L.-P., Yang, S., Fang, X., Wen, L., Ren, Q., & Yu, C. (2015) · Oncology Reports · doi:10.3892/or.2015.4480 · Cited by 19 · see citing works
The Role of BRG1 in Antioxidant and Redox Signaling
You, S., Zhang, Y., Xu, J., Qian, H. R., Wu, S., Wu, B., Lu, S., Sun, Y., & Zhang, N. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6095673 · Cited by 19 · see citing works
Time‐ and strain‐specific downregulation of intestinal EPAS1 via miR‐148a by Bifidobacterium bifidum
Taïbi, A., Singh, N., Chen, J., Arioli, S., Guglielmetti, S., & Comelli, E. M. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600596 · Cited by 19 · see citing works
Seifert, V., Richter, S., Bechmann, N., Bachmann, M. P., Ziegler, C. G., Pietzsch, J., & Ullrich, M. (2021) · Cancers · doi:10.3390/cancers13030385 · Cited by 19 · see citing works
Xu, X., Zhang, J., Guo, Z., Song, M., Sun, R., Jin, X.-Y., Su, J.-D., & Sun, B. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-450 · Cited by 18 · see citing works
Zhang, Z., Li, Q., Wang, F., Ma, B., Meng, Y., & Zhang, Q. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.606816 · Cited by 17 · see citing works
Ali, K., Nabeel, M., Mohsin, F., Iqtedar, M., Islam, M. F., Rasool, M. F., Hashmi, F. K., Hussain, S. A., & Saeed, H. (2024) · Medical Oncology · doi:10.1007/s12032-024-02347-z · Cited by 19 · see citing works
Key genes and drug delivery systems to improve the efficiency of chemotherapy
Torres‐Martínez, Z., Delgado, Y., Ferrer‐Acosta, Y., Suárez-Arroyo, I. J., Joaquín-Ovalle, F. M., Delinois, L. J., & Griebenow, K. H. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.64 · Cited by 16 · see citing works
Non-canonical function of an Hif-1α splice variant contributes to the sustained flight of locusts
Ding, D., Zhang, J., Du, B., Wang, X., Hou, L., Guo, S., Chen, B., & Kang, L. (2022) · eLife · doi:10.7554/elife.74554 · Cited by 16 · see citing works
Wu, L., Zhou, J., Zhou, W., Huang, X., Chen, Q., Wang, W., Zhai, L., Li, S., & Tang, Z. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153270 · Cited by 15 · see citing works
Ray, S. K., Erukkambattu, J., Kotnis, A. L., & Mukherjee, S. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230309112751 · Cited by 14 · see citing works
Harashima, N., Takenaga, K., Akimoto, M., & Harada, M. (2017) · Oncotarget · doi:10.18632/oncotarget.17157 · Cited by 13 · see citing works
Role of ROS/Kv/HIF Axis in the Development of Hypoxia-Induced Pulmonary Hypertension
Wen, W., Li, Y., & Dunquan, X. (2017) · Chinese Medical Sciences Journal · doi:10.24920/j1001-9294.2017.037 · Cited by 12 · see citing works
Astrocyte HIF-2α supports learning in a passive avoidance paradigm under hypoxic stress
Leiton, C. V., Chen, E., Cutrone, A. M., Conn, K., Mellanson, K. A., Malik, D. M., Klingener, M., Lamm, R. J., Cutrone, M., Petrie, J. C., et al. (2018) · Hypoxia · doi:10.2147/hp.s173589 · Cited by 12 · see citing works
Hif1a and Hif2a can be safely inactivated in cone photoreceptors
Samardzija, M., Barben, M., Todorova, V., Klee, K., Storti, F., & Grimm, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-52508-8 · Cited by 12 · see citing works
Seifert, V., Liers, J., Knieß, T., Richter, S., Bechmann, N., Feldmann, A., Bachmann, M. P., Eisenhofer, G., Pietzsch, J., & Ullrich, M. (2019) · Journal of Cellular Biotechnology · doi:10.3233/jcb-199005 · Cited by 12 · see citing works
Expression and Regulation of Hypoxia-Inducible Factor Signalling in Acute Lung Inflammation
Lotsios, N. S., Keskinidou, C., Karagiannis, S. P., Papavassiliou, K. A., Papavassiliou, A. G., Kotanidou, Α., Dimopoulou, I., Orfanos, S. E., & Vassiliou, A. G. (2024) · Cells · doi:10.3390/cells14010029 · Cited by 10 · see citing works
Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade
Tátrai, E., Ranđelović, I., Surguta, S. E., & Tóvári, J. (2024) · Cancers · doi:10.3390/cancers16101872 · Cited by 10 · see citing works
Yang, Y., Chen, W., Mai, W., & Gao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.998295 · Cited by 10 · see citing works
Dynamics of oxygen level-driven regulators in modulating autophagy in colorectal cancer cells
Tam, S. Y., Wu, V., & Law, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.043 · Cited by 10 · see citing works
Joseph, I., Elizabeth, J., Rao, U. K., & Ranganathan, K. (2020) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_42_19 · Cited by 9 · see citing works
Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis
Qin, F., Xu, Z., Yuan, L., Chen, W., Wei, J., Sun, Y., & Li, S. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12934 · Cited by 9 · see citing works
Oxygen and metabolic reprogramming in the tumor microenvironment influences metastasis homing
Bisht, V. S., Giri, K., Kumar, D., & Ambatipudi, K. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1992233 · Cited by 8 · see citing works
Li, J.-F., Zheng, X.-R., Zhang, H.-Y., Shen, C., Shen, G.-X., & Jiang, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1911311 · Cited by 8 · see citing works
Self-citationChen, Y., Yang, L., Liu, N., Shi, Q., Yin, X., Han, X., Gan, W., & Li, D. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666210412115026 · Cited by 8 · see citing works
Haque, M., & Kousoulas, K. G. (2019) · Journal of Virology · doi:10.1128/jvi.00764-19 · Cited by 8 · see citing works
Circadian disruption dysregulates lung gene expression associated with inflammatory lung injury
Casanova, N. G., Armond, R. L. D., Sammani, S., Sun, X., Sun, B. L., Kempf, C. L., Bime, C., Garcia, J. G. N., & Parthasarathy, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1348181 · Cited by 7 · see citing works
Regulation of Cancer‐Associated miRNAs Expression under Hypoxic Conditions
Valencia-Cervantes, J., & Sierra-Vargas, M. P. (2024) · Analytical Cellular Pathology · doi:10.1155/2024/5523283 · Cited by 6 · see citing works
Expression of Hypoxia-Inducible Factors in Different Stages of Pancreatic Tumor Progression
Jung, J. H., Sosnowska, D., Weaver, J., Parson, H. K., CASELLINI, C. M., & Vinik, A. I. (2020) · Reports — Medical Cases Images and Videos · doi:10.3390/reports3040030 · Cited by 6 · see citing works
HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil
Mori, N., Mironchik, Y., Wildes, F. B., Wu, S. Y., Mori, K., Krishnamachary, B., & Bhujwalla, Z. M. (2020) · Current Cancer Reports · doi:10.25082/ccr.2020.01.005 · Cited by 6 · see citing works
Mahadevan, A., Yazdanpanah, O., Patel, V., Benjamin, D. J., & Kalebasty, A. R. (2024) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2024.101171 · Cited by 5 · see citing works
Stabilization of HIF-2α impacts pancreas growth
Flores-Martinez, Á., García-Núñez, A., Rojas, A., & Cano, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32054-5 · Cited by 3 · see citing works
Zheng, F., Du, F., & Zhao, J. (2016) · Medicine · doi:10.1097/md.0000000000002871 · Cited by 4 · see citing works
Self-citationHypoxic Tumor Microenvironment: Driver for Cancer Progression
Dutta, S., & Sahoo, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_4 · Cited by 3 · see citing works
Mahapatra, N., Panda, A., Dash, K. C., Bhuyan, L., Mishra, P., & Mohanty, A. (2023) · Cureus · doi:10.7759/cureus.45189 · Cited by 3 · see citing works
Hypoxia, Angiogenesis and Atherogenesis
Heikal, L., & Ferns, G. A. (2017) · InTech eBooks · doi:10.5772/66714 · Cited by 3 · see citing works
Malignant transformation of oral submucous fibrosis
Hegde, S., Anuradha, A., & Asha, V. (2015) · Journal of Medicine Radiology Pathology & Surgery · doi:10.15713/ins.jmrps.34 · Cited by 3 · see citing works
HIF inhibition: Current strategies and clinical challenges
Więch-Walów, A., Bartoszewska, S., Barton, A., Czechowicz, P., Dudzik, J., Wielockx, B., Collawn, J. F., & Bartoszewski, R. (2026) · Redox biology · doi:10.1016/j.redox.2026.104220 · Cited by 3 · see citing works
“Erythropoietin ( EPO ) is often considered a prototypical HIF-2 target [65,100], although regulation by all three HIF isoforms has also been reported [101].”
Zarychta, J., Kowalczyk, A., Słowik, K., Przywara, D., Petniak, A., Kondracka, A., Wójtowicz‐Marzec, M., Słyk-Gulewska, P., Kwaśniewska, A., Kocki, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011042 · Cited by 2 · see citing works
A dynamic model of gene activation in response to hypoxia accounting for both HIF-1 and HIF-2
Cabaj, A., Charzyńska, A., Moszyńska, A., Jaśkiewicz, M., Bartoszewski, R., & Dąbrowski, M. (2025) · Briefings in Functional Genomics · doi:10.1093/bfgp/elaf021 · Cited by 2 · see citing works
- Authors
- Zhao, J., Du, F., Shen, G., Zheng, F., & Xu, B.
- Affiliations
- Qinghai University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Corresponding author
- Xu, B
- Venue
- Cell Death & Disease
- Published
- 2015-01-15
- Volume
- 6
- Issue
- 1
- Pages
- e1600-e1600
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC4669763
- OpenAlex
- W2039630990
- Cited by
- 122
- References
- 111
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 16 · 2023: 6 · 2022: 11 · 2021: 9 · 2020: 17 · 2019: 12 · 2018: 15 · 2017: 9 · 2016: 11 · 2015: 8
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81360318)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- HIF-2α, HIF-2, gastrointestinal cancer, tumor hypoxia, carcinogenesis, angiogenesis, cell proliferation, apoptosis, cancer metabolism, metastasis, chemoresistance
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Digestive System Neoplasms, Humans, Neovascularization, Pathologic, Drug Resistance, Neoplasm, Cell Proliferation, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review